Resultados de la búsqueda 251-260 of 18735 for Two-phase

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

2. Oncología (médica) - Ensayos clínicos

   ... phase 2 dose (RP2D) of APG-2575. Understanding the Relationship Between Benign Breast Tissue, Benign Breast Disease, and Breast Cancer Development.

3. Oncología (médica) - Ensayos clínicos

   In Part 2 Cohort 1, an expansion phase at the established RP2D will be undertaken in participants with selected advanced solid tumors. In Part 2 Cohort 2, a ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... phase 2 dose (RP2D) of APG-2575. Understanding the Relationship Between Benign Breast Tissue, Benign Breast Disease, and Breast Cancer Development.

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... phase 2 dose (RP2D) of APG-2575. Understanding the Relationship Between Benign Breast Tissue, Benign Breast Disease, and Breast Cancer Development.

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma ...

8. Oncología (médica) - Ensayos clínicos

   ... phase. AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) ... two prior lines of therapies. The study has 2 Modules: Module 1 for FL and Module ...

9. Oncología (médica) - Ensayos clínicos

   In Part 2 Cohort 1, an expansion phase at the established RP2D will be undertaken in participants with selected advanced solid tumors. In Part 2 Cohort 2, a ...

10. Oncología (médica) - Ensayos clínicos

    In Part 2 Cohort 1, an expansion phase at the established RP2D will be undertaken in participants with selected advanced solid tumors. In Part 2 Cohort 2, a ...